Treatment & Recovery
Prenatal maternal opioid use has increased considerably over the past decade. Neonatal abstinence syndrome (NAS) rates increased five-fold between 2004 and 2014 and approximately 70% of women entering substance use treatment services have children. While Medication-assisted treatment (MAT) has been recognized as an effective treatment for pregnant women with opioid use disorder (OUD), additional services and supports are often required. Family-centered treatment, which promotes inclusion of social and community-based services and treats the entire family instead of just women with OUD, can improve pregnancy outcomes, remove mothers from the drug-use environment, and engage them in a network of support. This promotes sustainable recovery, improving long-term outcomes for mothers and children.
Based on a scan of the 20 states hit hardest by the opioid epidemic, presenters describe successful state and local strategies to support a model of family-centered treatment for women with OUD. They will outline successful state legislation and policies, funding strategies, and cross-agency collaborations supporting family-centered services for pregnant and postpartum women with OUD and their families. They will present a graphical representation of a gold-standard model for states to implement family-centered care. Additionally, they will present an applied perspective on the challenges and opportunities related to treating this unique population through themes identified from 11 key informant interviews, including observations from researchers, state and federal policymakers, and providers.
This session is accredited for the following accreditation types: CME, CNE, CPE, APA, AAFP, AAHCPAD*, NAADAC*, ASWB*
*State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit.